Semaglutide mimics the GLP-1 hormone, targeting brain areas involved in appetite regulation, helping you feel fuller longer and reducing food intake
Weight Loss Diabetes Drug Industry Leaders Eli Lilly Novo Nordisk Boehringer Ingelheim Amylin Pharmaceuticals Harman Finochem *Disclaimer: Major Players sorted in no particular order Recent Industry Developments April 2025: Drugmaker Eli Lilly announced that oral GLP-1 candidate orforglipron cut HbA1c by 1.31.6 points and induced 7.9% body-weight loss in Phase 3 trials
Could these medications help with conditions like MCAS (Mast Cell Activation Syndrome), fatigue, and even neurodegenerative diseases
When a patient's blood sugar levels are high, GLP-1 drugs send signals to their pancreas to secrete more insulin but the hormone-mimicking doesn't stop there
Minimal Discomfort With Insulin Syringes Subcutaneous injection are easy and pain free (if you can handle a mosquito bite, you can handle an insulin needle)
Both phentermine and semaglutide can help with weight loss, but they work differently and suit different needs